Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients

ANTICANCER RESEARCH

Kiss, I; Mlcochova, J; Bortlicek, Z; Poprach, A; Drabek, J; Vychytilova-Faltejskova, P; Svoboda, M; Buchler, T; Batko, S; Ryska, A; Hajduch, M; Slaby, O, 2016: Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients. ANTICANCER RESEARCH 36(9), p. 4955 - 4959, doi: 10.21873/anticanres.11063

Research Groups:

CEITEC authors: